Regeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKP

Biomaterials. 2014 Mar;35(8):2436-45. doi: 10.1016/j.biomaterials.2013.12.011. Epub 2013 Dec 28.


Regeneration of chronic myocardial infarction (CMI) is one of the challenging issues due to its limited regeneration activity compared to acute or sub-acute stage. In this study, we examined whether combination of stem cell homing factor (SDF-1) and angiogenic peptides (Ac-SDKP) injected with biomimetic hydrogels promote regeneration of cardiac function in a CMI model. We evaluated the regeneration of chronically infarcted myocardium using injectable biomimetic hydrogels containing two therapeutic factors; stromal-derived factor-1 (SDF-1) and Ac-SDKP for stem cell homing and angiogenesis, respectively. Injection of the two therapeutic factors into the infarct region of the left ventricle showed that the biomimetic hydrogels containing two therapeutic factor exhibited significantly improved left ventricle function, increased angiogenesis, decreased infarct size and greatest wall thickness within the infarct region at 4 weeks post-treatment. From these results, it is clear that hydrogels containing two therapeutic factors showed synergistic effects on regeneration in the chronic heart failure model. In conclusion, these results suggest that combination of stem cell homing factor with angiogenic peptides recruit stem cells to the microenvironments, increase the expression of angiogenic genes, enhance the matured vessel formation and improve the cardiac function in chronic MI.

Keywords: Ac-SDKP; Chronic heart failure; Controlled release system; Hydrogel; Matrix metalloproteinase (MMP); SDF-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biocompatible Materials / therapeutic use*
  • Cells, Cultured
  • Chemokine CXCL12 / genetics
  • Chemokine CXCL12 / pharmacology*
  • Drug Synergism
  • Gene Expression
  • Humans
  • Hydrogels / chemical synthesis*
  • Male
  • Mesenchymal Stem Cells / metabolism
  • Myocardial Infarction / therapy*
  • Myocardium / metabolism
  • Neovascularization, Physiologic / drug effects
  • Oligopeptides / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, CXCR4 / metabolism
  • Regeneration / drug effects*
  • Transcriptome
  • Ventricular Function, Left


  • Biocompatible Materials
  • CXCL12 protein, human
  • Chemokine CXCL12
  • Cxcr4 protein, rat
  • Hydrogels
  • Oligopeptides
  • Receptors, CXCR4
  • goralatide